Henry Krum
Impact in
- Cardiology and Cardiovascular Medicine top 0.01%
- Heart Failure Treatment and Management
- Blood Pressure and Hypertension Studies
- Cardiovascular Function and Risk Factors
- Cardiac pacing and defibrillation studies
- Heart Rate Variability and Autonomic Control
- Cardiac electrophysiology and arrhythmias
- Endocrinology, Diabetes and Metabolism top 0.05%
- Hormonal Regulation and Hypertension
- Diabetes Treatment and Management
Papers in
-
- Heart Failure Treatment and Management 167
- Blood Pressure and Hypertension Studies 88
- Cardiovascular Function and Risk Factors 61
- Heart Rate Variability and Autonomic Control 50
- Cardiac pacing and defibrillation studies 41
- Cardiac Fibrosis and Remodeling 31
- Cardiac electrophysiology and arrhythmias 25
-
- Hormonal Regulation and Hypertension 77
- Co-authors
- John J.V. McMurray (48 shared papers)Markus P. Schlaich (48 shared papers)Murray Esler (42 shared papers)Faı̈ez Zannad (30 shared papers)William T. Abraham (26 shared papers)Milton Packer (19 shared papers)Dirk J. van Veldhuisen (32 shared papers)Karl Swedberg (20 shared papers)
- Journals
- European Journal of Heart Failure (38 papers)Journal of the American College of Cardiology (34 papers)Circulation (34 papers)Journal of Cardiac Failure (24 papers)International Journal of Cardiology (20 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
Henry Krum
555 papers receiving 35.6k citations
Henry Krum's Hit Papers
Peers
Comparison fields: 5 of 171
- Cardiology and Cardiovascular Medicine 22.5k
- Endocrinology, Diabetes and Metabolism 5.8k
- Nephrology 1.3k
- Family Practice 220
- Complementary and alternative medicine 989
Countries citing papers authored by Henry Krum
This map shows the geographic impact of Henry Krum's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Henry Krum with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Henry Krum more than expected).
Fields of papers citing papers by Henry Krum
This network shows the impact of papers produced by Henry Krum. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Henry Krum. The network helps show where Henry Krum may publish in the future.
Co-authors
The 25 scholars most cited alongside Henry Krum, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 571 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Effect of Carvedilol on Survival in Severe Chronic Heart Failure Hit paper breakdown → | 2001 | 2296 |
| 2 | Eplerenone in Patients with Systolic Heart Failure and Mild Symptoms Hit paper breakdown → | 2010 | 2170 |
| 3 | Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study Hit paper breakdown → | 2009 | 1450 |
| 4 | Targeted Anticytokine Therapy in Patients With Chronic Heart Failure Hit paper breakdown → | 2004 | 1003 |
| 5 | Effect of Carvedilol on the Morbidity of Patients With Severe Chronic Heart Failure Hit paper breakdown → | 2002 | 984 |
| 6 | Heart Failure: Preventing Disease and Death Worldwide Hit paper breakdown → | 2014 | 977 |
| 7 | Aliskiren, ALTITUDE, and the Implications for ATMOSPHERE Hit paper breakdown → | 2012 | 935 |
| 8 | Cardiac-Resynchronization Therapy in Heart Failure with a Narrow QRS Complex Hit paper breakdown → | 2013 | 542 |
| 9 | 2002 | 493 | |
| 10 | 1998 | 480 | |
| 11 | Safety and tolerability of the novel non-steroidal mineralocorticoid receptor antagonist BAY 94-8862 in patients with chronic heart failure and mild or moderate chronic kidney disease: a randomized, double-blind trial Hit paper breakdown → | 2013 | 473 |
| 12 | Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study Hit paper breakdown → | 2013 | 446 |
| 13 | 2007 | 444 | |
| 14 | Effect of Renal Sympathetic Denervation on Glucose Metabolism in Patients With Resistant Hypertension Hit paper breakdown → | 2011 | 417 |
| 15 | Efficacy of β blockers in patients with heart failure plus atrial fibrillation: an individual-patient data meta-analysis Hit paper breakdown → | 2014 | 383 |
| 16 | 2006 | 369 | |
| 17 | 1996 | 355 | |
| 18 | 2012 | 337 | |
| 19 | A randomized controlled study of finerenone vs. eplerenone in patients with worsening chronic heart failure and diabetes mellitus and/or chronic kidney disease Hit paper breakdown → | 2016 | 317 |
| 20 | 1995 | 294 |
About Henry Krum
Henry Krum is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Surgery, Pharmacology and Molecular Biology, having authored 571 papers that have together received 37.1k indexed citations. Recurring topics across this work include Heart Failure Treatment and Management (167 papers), Blood Pressure and Hypertension Studies (88 papers), Hormonal Regulation and Hypertension (77 papers), Cardiovascular Function and Risk Factors (61 papers), Heart Rate Variability and Autonomic Control (50 papers), Cardiac pacing and defibrillation studies (41 papers), Cardiac Fibrosis and Remodeling (31 papers) and Cardiac electrophysiology and arrhythmias (25 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (22.5k citations), Endocrinology, Diabetes and Metabolism (5.8k citations), Nephrology (1.3k citations), Family Practice (220 citations) and Complementary and alternative medicine (989 citations). Henry Krum has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include John J.V. McMurray, Markus P. Schlaich, Murray Esler, Faı̈ez Zannad, William T. Abraham, Milton Packer, Dirk J. van Veldhuisen, Karl Swedberg, Jean L. Rouleau and John Vincent. Their work appears in journals such as European Journal of Heart Failure, Journal of the American College of Cardiology, Circulation, Journal of Cardiac Failure and International Journal of Cardiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.